Live Narayana Hrudayalaya Share Price Chart

O 1263

H 1263

L 1263

VOL 282

Narayana Hrudayalaya Performance

Days Range

Low: ₹1,263.00
High: ₹1,297.00
Previous Close ₹1,269.15
Open ₹1,263.00
Volume 2,69,770
Day’s Range ₹1,263.00 - ₹1,297.00
52W Range ₹746.30 - ₹1,444.90
Market Cap ₹25,907 Cr

Narayana Hrudayalaya Fundamentals

ROCE (TTM) 24.95
P/E Ratio (TTM) 33.57
P/B Ratio 10.36
Industry P/E 68.95
Debt to Equity 0.43
ROE 29.48
EPS (TTM) 37.76
Dividend Yield 0.2
Book Value 122.42
Face Value 10

Narayana Hrudayalaya Financials

Mar 2023Jun 2023Sep 2023Dec 2023
Net Sales1,221.591,233.431,305.251,203.64
Expenses1,002.151,021.641,052.41987.88
Profit before tax213.53205.94248.39208.59
Operating Profit173.24184.05226.69188.11
Net Profit173.24184.05226.69188.11
EPS in Rs8.539.0611.169.26

About Narayana Hrudayalaya

History

Narayana Hrudayalaya Limited was established on July 19, 2000, by its founder, Dr. Devi Prasad Shetty. Narayana Hrudayalaya Limited is the group’s flagship entity. The organisation boasts a comprehensive network comprising 23 multi-speciality and super-speciality hospitals, along with 7 heart centres distributed over 18 locations in India and a multi-speciality hospital in the Cayman Islands.

In the financial year concluding on March 31, 2016, the company fully acquired Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL) from Infrastructure Development Corporation (Karnataka) Limited (IDECK), purchasing the remaining 26% stake for ₹3,025.60 lakh. 

That year, the company expanded internationally, collaborating with Kenyan doctors and international financial institutions to launch a multi-specialty hospital in Nairobi, Kenya. This venture saw the company initially holding a 26% equity stake, amounting to $1.325 million. 

Asia Healthcare Development Limited (AHDL), a fully-owned subsidiary engaged in hospital operations and related activities, was sold in November 2016 to Lila Hospitals Private Limited for ₹38.34 lakh. The company’s initial public offering (IPO) in December 2015 led to the sale of 2.45 crore equity shares by promoters and other shareholders, including JP Morgan Mauritius Holdings, Ambadevi Mauritius Holdings, and Ashoka Investment Holdings. The shares were listed on the BSE Limited and National Stock Exchange of India Limited on January 6, 2016.

In 2017, the company launched a 30-bed platinum wing at Mazumdar Shaw Medical Centre in Bengaluru and partnered with Cisco for remote diagnostic capabilities. Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL) also signed an agreement to operate a hospital in New Delhi.

Further expansion in the financial year ending March 31, 2018, included the commissioning of SRCC Children’s Hospital in Mumbai and the acquisition of a hospital in Gurugram. The merger of NewRise Healthcare Private Limited with Narayana Hrudayalaya and the consolidation of Narayana Cayman Holdings Ltd. with Health City Cayman Islands Ltd. were other key developments.

In 2023, Health City Cayman Islands Ltd. (HCCI) acquired ENT in Cayman Ltd., making it a wholly-owned subsidiary. The company also acquired an Orthopaedic and Trauma Hospital from Shiva and Shiva Orthopaedic Hospital Private Limited. It expanded its services in various specialities, including the first-ever cadaveric liver and kidney transplant at DNSH Delhi and the commissioning of a new LINAC machine in Jaipur.

Business Segments 

As of March 31, 2023, Narayana Health, headquartered in Bengaluru, India, operates with one business segment: healthcare. The organisation operates 21 hospitals, including one in the Cayman Islands, and 6 heart centres, with over 5,859 operational beds. The group provides affordable, high-quality healthcare in over 30 specialities, including Cardiology, Cancer Care, Neurology, Orthopaedics, Nephrology, Urology, and Gastroenterology.

Subsidiaries of Narayana Hrudalaya

As of March 31, 2023, the company has 14 subsidiaries and 2 associate companies. Some of them are: 

  1. Narayana Hrudayalaya Surgical Hospital Private Limited (NHSHPL): A wholly-owned subsidiary of the company, NHSHPL operates a multi-specialty hospital in Mysore and the Dharamshila Narayana Superspecialty Hospital in Delhi. It offers services in various specialities like cardiology, neurology, orthopaedics, and oncology.
  2. Meridian Medical Research & Hospital Ltd. (MMRHL): Another subsidiary of the company, MMRHL, manages two hospitals in Howrah, providing multi and super-speciality healthcare services, including nephrology, neurology, and neurosurgery.
  3. Narayana Vaishno Devi Specialty Hospitals Private Limited (NVDSHPL): A wholly-owned subsidiary, NVDSHPL runs a hospital in Kakryal, Jammu, offering services in over 20 specialities such as radiology, obstetrics & gynaecology, and oncology. 

Key Personnel 

Dr Devi Prasad Shetty, Chairman and Founder

Dr Shetty, a professor at Rajiv Gandhi University and University of Minnesota Medical School, is renowned for receiving prestigious awards like the ‘Padma Shri’ (2003), ‘Padma Bhushan’ (2012), and ‘Rajyotsava Award’ (2002). He earned the ‘Dr. B C Roy National Award’ (2003), ‘Entrepreneur of the Year’ by Ernst & Young, and the ‘Sir M. Visveswaraya Memorial Award’. He is also a member of the European Association for Cardio-Thoracic Surgery and has made significant contributions to medical sciences.

Management Outlook 

  • According to a NITI Aayog report, 70% of India’s population has health insurance, leaving a ‘missing middle’ 30% uninsured. Tapping this market requires innovative, affordable insurance products and integrated healthcare services.
  • The budget boosts healthcare by establishing 157 nursing colleges, opening ICMR labs to manufacturers and corporations, and introducing comprehensive medical device courses, benefiting med-tech startups and hospitals.
Parent Organisation Indian Private
Founded 2000
Managing Director DEVI PRASAD SHETTY
NSE Symbol NH

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Aster DM Healthcare Ltd ₹26,112.05

519.95

2.80 (-0.54%)

519 - 537.7View Peer Comparison
Opto Circuits (India) Ltd ₹53.51

1.8

0.00 (0.00)

1.8 - 1.85View Peer Comparison
Indraprastha Medical Corporation Ltd ₹2,064.41

231.1

5.65 (2.51%)

218.95 - 241.2View Peer Comparison
Sangani Hospitals Ltd ₹61.03

45.35

1.05 (2.37%)

44.1 - 48View Peer Comparison
Krsnaa Diagnostics Ltd ₹1,913.98

584.7

9.00 (-1.52%)

581.4 - 599View Peer Comparison

What's Trending

Narayana Hrudayalaya FAQs

What is the Share price of Narayana Hrudayalaya (NH)?

Narayana Hrudayalaya (NH) share price as of April 16, 2024, on NSE is Rs 1,277.50 (NSE) and Rs 1,276.95 (BSE) on BSE.

Can I buy Narayana Hrudayalaya (NH) shares?

Yes, You can buy Narayana Hrudayalaya (NH) shares by opening a Demat account with Angel One.

How do I buy Narayana Hrudayalaya (NH) from Angel One?

Narayana Hrudayalaya (NH) share can be brought through the following modes:
  1. Direct investment: You can buy Narayana Hrudayalaya (NH) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Narayana Hrudayalaya (NH) shares.

Is Narayana Hrudayalaya a Debt free Company?

Yes, Narayana Hrudayalaya is a virtually debt free company.

What is the main business of Narayana Hrudayalaya?

Narayana Hrudayalaya is a healthcare provider that specialises in cardiology, oncology, and neurology. Their main business is to provide patients in India and other countries with high-quality medical care.

Who are the promoters of Narayana Hrudayalaya?

Shakuntala Shetty, and Devi Prasad Shetty are the major promoters of Narayana Hrudayalaya.

What are the Subsidiaries that comes under Narayana Hrudayalaya?

Health City Cayman Islands, Narayana Health City Bangalore, Narayana Hrudayalaya Dubai, Narayana Multispeciality Hospital Jaipur, Narayana Superspeciality Hospital Howrah, and others are all subsidiaries of Narayana Hrudayalaya.